Using real-world data to develop clinical trial referral networks for metastatic renal cell carcinoma (mRCC).

e16556Background: As of February 2018, there are 16 ongoing global Phase III clinical trials in mRCC (with 11 in the US) in the first-line setting involving 1300 sites and 9600 patients (pts). To i...